Patents by Inventor Steven A. Teitelbaum
Steven A. Teitelbaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11248036Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: GrantFiled: December 17, 2019Date of Patent: February 15, 2022Assignee: Washington UniversityInventors: Christopher Nelson, Steven Teitelbaum, Daved Fremont, Julia T. Warren
-
Publication number: 20200199196Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: ApplicationFiled: December 17, 2019Publication date: June 25, 2020Inventors: Christopher Nelson, Steven Teitelbaum, Daved Fremont, Julia T. Warren
-
Patent number: 10550169Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: GrantFiled: February 12, 2018Date of Patent: February 4, 2020Assignee: Washington UniversityInventors: Steven Teitelbaum, Daved Fremont, Julia T. Warren, Christopher Nelson
-
Publication number: 20180312569Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: ApplicationFiled: February 12, 2018Publication date: November 1, 2018Inventors: Steven Teitelbaum, Daved Fremont, Julia T. Warren, Christopher Nelson
-
Patent number: 9914761Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: GrantFiled: July 10, 2015Date of Patent: March 13, 2018Assignee: Washington UniversityInventors: Steven Teitelbaum, Daved Fremont, Julia T. Warren, Christopher Nelson
-
Publication number: 20160009783Abstract: Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.Type: ApplicationFiled: July 10, 2015Publication date: January 14, 2016Inventors: Steven Teitelbaum, Daved Fremont, Julia T. Warren, Christopher Nelson
-
Patent number: 8381410Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: GrantFiled: June 8, 2011Date of Patent: February 26, 2013Assignee: Allergan, Inc.Inventors: William P. Adams, Jr., Bradley P. Bengston, Steven A. Teitelbaum
-
Publication number: 20110238175Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: ApplicationFiled: June 8, 2011Publication date: September 29, 2011Applicant: ALLERGAN, INC.Inventors: William P. Adams, JR., Steven Teitelbaum, Bradley P. Bengston
-
Patent number: 7979996Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: GrantFiled: February 18, 2010Date of Patent: July 19, 2011Assignee: Allergan, Inc.Inventors: William P. Adams, Jr., Bradley P. Bengtson, Steven A. Teitelbaum
-
Publication number: 20100234944Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: ApplicationFiled: February 18, 2010Publication date: September 16, 2010Applicant: ALLERGAN, INC.Inventors: William P. ADAMS, JR., Steven TEITELBAUM, Bradley P. BENGTSON
-
Patent number: 7685721Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: GrantFiled: July 10, 2008Date of Patent: March 30, 2010Assignee: Allergan, Inc.Inventors: William P. Adams, Jr., Steven Teitelbaum, Bradley P. Bengtson
-
Publication number: 20090069891Abstract: A breast implant selector system including a breast width selector for selecting breast width input information, a breast tissue type selector for selecting breast tissue type input information in response to breast width input information selected with the breast width selector, and an implant size selector for selecting implant size input information in response to the breast tissue type input information selected with the breast tissue type selector. A result indicator provides a result characterizing at least one suggested breast implant as a function of the input breast width, breast tissue type, and implant size input information.Type: ApplicationFiled: July 10, 2008Publication date: March 12, 2009Inventors: William P. Adams, JR., Steven Teitelbaum, Bradley P. Bengtson